Teleflex | TFX - Ebitda


Teleflex reported $75.63M in EBITDA for its fiscal quarter ending in March of 2026.





Ebitda Change Date
Abbott USD 2.43B 844M Mar/2026
Align Technology USD 229.14M 31.74M Mar/2026
AngioDynamics USD 5.94M 3.78M Sep/2025
AtriCure USD 27.28M 10.21M Jun/2026
Baxter International USD 309M 756M Mar/2026
Becton, Dickinson and Co. USD 1.71B 433M Dec/2025
Boston Scientific USD 1.63B 27M Jun/2026
Cooper Companies USD 323.4M 13.2M Dec/2025
Dexcom USD 364.5M 57.7M Mar/2026
Edwards Lifesciences USD 555.6M 485.5M Mar/2026
General Electric Aerospace USD 3.06B 219M Jun/2026
Globus Medical USD 231.83M 48.62M Mar/2026
Haemonetics USD 94.78M 20.75M Dec/2025
Insulet USD 199.8M 18.1M Jun/2026
Integra LifeSciences USD 78.41M 2.23M Jun/2026
Intuitive Surgical USD 1.06B 29.9M Mar/2026
J&J USD 8.27B 1.08B Mar/2026
Medtronic USD 2.81B 119M Mar/2026
Merit Medical Systems USD 104.39M 10.97M Jun/2026
Orthofix International USD 27.88M 2.77M Dec/2025
ResMed USD 547.48M 27.46M Dec/2025
Steris USD 443M 48.3M Mar/2026
Stryker USD 1.93B 357M Jun/2026
Tandem Diabetes Care USD 2.73M 30.17M Mar/2026
Teleflex USD 75.63M 171.44M Mar/2026
Zimmer Biomet Holdings USD 830.5M 190.4M Jun/2026